Susquehanna International Group’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-9,576
| Closed | -$227K | – | 14474 |
|
|
2021
Q4 | $227K | Buy |
+9,576
| New | +$236K | ﹤0.01% | 11184 |
|
|
2021
Q3 | – | Sell |
-14,100
| Closed | -$366K | – | 13938 |
|
|
2021
Q2 | $366K | Buy |
14,100
+902
| +7% | +$24.5K | ﹤0.01% | 10345 |
|
|
2021
Q1 | $338K | Sell |
13,198
-5,607
| -30% | -$144K | ﹤0.01% | 10356 |
|
|
2020
Q4 | $377K | Buy |
18,805
+5,705
| +44% | +$112K | ﹤0.01% | 8846 |
|
|
2020
Q3 | $224K | Sell |
13,100
-11,303
| -46% | -$214K | ﹤0.01% | 9280 |
|
|
2020
Q2 | $532K | Buy |
24,403
+14,198
| +139% | +$325K | ﹤0.01% | 7224 |
|
|
2020
Q1 | $236K | Buy |
+10,205
| New | +$297K | ﹤0.01% | 8410 |
|
|
2019
Q4 | – | Sell |
-15,076
| Closed | -$483K | – | 10988 |
|
|
2019
Q3 | $480K | Buy |
15,076
+101
| +0.7% | +$2.94K | ﹤0.01% | 7393 |
|
|
2019
Q2 | $385K | Buy |
+14,975
| New | +$382K | ﹤0.01% | 7811 |
|
|
2019
Q1 | – | Sell |
-41,480
| Closed | -$1.24M | – | 10182 |
|
|
2018
Q4 | $1.41M | Buy |
+41,480
| New | +$1.35M | ﹤0.01% | 4078 |
|
|
2018
Q3 | – | Sell |
-13,886
| Closed | -$490K | – | 10562 |
|
|
2018
Q2 | $479K | Sell |
13,886
-2,887
| -17% | -$101K | ﹤0.01% | 6879 |
|
|
2018
Q1 | $564K | Buy |
+16,773
| New | +$531K | ﹤0.01% | 6392 |
|
|
2017
Q3 | – | Sell |
-28,777
| Closed | -$1.02M | – | 9904 |
|
|
2017
Q2 | $1.07M | Buy |
+28,777
| New | +$1.04M | ﹤0.01% | 5110 |
|
|
2017
Q1 | – | Sell |
-67,231
| Closed | -$2.52M | – | 10316 |
|
|
2016
Q4 | $2.34M | Buy |
+67,231
| New | +$2.64M | ﹤0.01% | 3736 |
|
|
2016
Q2 | – | Sell |
-7,200
| Closed | -$241K | – | 9567 |
|
|
2016
Q1 | $277K | Sell |
7,200
-25,960
| -78% | -$967K | ﹤0.01% | 7395 |
|
|
2015
Q4 | $1.59M | Sell |
33,160
-30,105
| -48% | -$1.39M | ﹤0.01% | 4504 |
|
|
2015
Q3 | $2.5M | Sell |
63,265
-28,633
| -31% | -$1.22M | ﹤0.01% | 3852 |
|
|
2015
Q2 | $3.91M | Buy |
91,898
+50,733
| +123% | +$2.02M | ﹤0.01% | 3360 |
|
|
2015
Q1 | $1.63M | Sell |
41,165
-4,093
| -9% | -$151K | ﹤0.01% | 4727 |
|
|
2014
Q4 | $1.63M | Buy |
45,258
+32,023
| +242% | +$1.08M | ﹤0.01% | 4858 |
|
|
2014
Q3 | $391K | Sell |
13,235
-85,801
| -87% | -$2.37M | ﹤0.01% | 7629 |
|
|
2014
Q2 | $2.49M | Sell |
99,036
-102,211
| -51% | -$2.53M | ﹤0.01% | 4232 |
|
|
2014
Q1 | $5.19M | Buy |
201,247
+128,298
| +176% | +$3.23M | ﹤0.01% | 2834 |
|
|
2013
Q4 | $1.64M | Buy |
+72,949
| New | +$1.41M | ﹤0.01% | 4623 |
|
Other funds holding NTUS
Susquehanna International Group's NTUS Position: Q1 2022 in Review
Susquehanna International Group sold out of Natus Medical Inc (NTUS) in Q1 2022, closing a stake of 9,576 shares — an estimated $227K sold.
Susquehanna International Group first reported a position in NTUS in Q4 2013 and held it in 24 quarters. The position peaked at $5.19M in Q1 2014. 172 funds tracked by Wall St. Rank hold NTUS as of Q1 2022.
- Susquehanna International Group reported no remaining Natus Medical Inc position as of Q1 2022 after selling out during the quarter.
- Susquehanna International Group sold 9,576 Natus Medical Inc shares in Q1 2022, an estimated $227K.
- Susquehanna International Group first reported a position in Natus Medical Inc in Q4 2013 and held it in 24 quarters.
- Susquehanna International Group's Natus Medical Inc position peaked at $5.19M in Q1 2014.
- 172 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2022.
Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.